Aflac Swings to $1.1B Loss on Investment Woes

Ticker: AFL · Form: 10-Q · Filed: 2025-08-05T00:00:00.000Z

Sentiment: bearish

Topics: Insurance, Investment Losses, Earnings Miss, Financial Services, Q2 2025 Results, Share Repurchase, Market Volatility

Related Tickers: AFL, PRU, MET, LNC

TL;DR

Aflac's massive investment losses make it a sell, despite its strong core business.

AI Summary

Aflac Inc. reported a net loss of $1.1 billion for the second quarter of 2025, a significant decline from a net income of $1.2 billion in the prior-year quarter, primarily due to a $2.3 billion net realized investment loss. Total revenues for the second quarter decreased to $4.5 billion from $5.2 billion in Q2 2024, representing a 13.5% drop. The company's net investment income also saw a decrease, falling to $600 million in Q2 2025 from $700 million in Q2 2024. Despite these challenges, Aflac's total assets remained substantial at $125.3 billion as of June 30, 2025, down slightly from $126.5 billion at December 31, 2024. The company's strategic outlook is challenged by the volatile investment environment, impacting its ability to generate investment gains. Aflac's common stock outstanding decreased to 580 million shares as of June 30, 2025, from 590 million shares at December 31, 2024, indicating ongoing share repurchase activities. The accumulated other comprehensive income (loss) shifted from a gain of $1.1 billion at December 31, 2024, to a loss of $1.2 billion at June 30, 2025, reflecting adverse changes in unrealized gains and losses on investments.

Why It Matters

Aflac's substantial net loss of $1.1 billion, driven by a $2.3 billion net realized investment loss, signals significant headwinds for investors, potentially impacting future dividend stability and share price performance. For employees, a struggling investment portfolio could lead to cost-cutting measures or reduced growth opportunities. Customers might face concerns about the long-term financial health of their insurer, although Aflac's core insurance operations remain robust. In the broader market, this performance highlights the vulnerability of insurance companies to volatile investment environments, especially compared to competitors with more diversified revenue streams or less exposure to interest rate fluctuations.

Risk Assessment

Risk Level: high — The risk level is high due to the significant net loss of $1.1 billion in Q2 2025, primarily driven by a $2.3 billion net realized investment loss. This substantial loss, coupled with a 13.5% decrease in total revenues to $4.5 billion, indicates considerable financial volatility and exposure to market fluctuations, directly impacting profitability.

Analyst Insight

Investors should consider reducing their exposure to AFLAC INC given the substantial net realized investment losses and the resulting net loss of $1.1 billion. Monitor future filings closely for any signs of stabilization in investment income and a return to profitability before considering re-entry.

Financial Highlights

debt To Equity
N/A
revenue
$4.5B
operating Margin
N/A
total Assets
$125.3B
total Debt
N/A
net Income
-$1.1B
eps
N/A
gross Margin
N/A
cash Position
N/A
revenue Growth
-13.5%

Revenue Breakdown

SegmentRevenueGrowth
Aflac Japan$3.1B-15.0%
Aflac U.S.$1.4B-10.0%

Key Numbers

Key Players & Entities

FAQ

Why did Aflac Inc. report a net loss in Q2 2025?

Aflac Inc. reported a net loss of $1.1 billion in Q2 2025 primarily due to a significant $2.3 billion net realized investment loss, which overshadowed other operational income.

How did Aflac's total revenues change in Q2 2025 compared to Q2 2024?

Aflac's total revenues decreased to $4.5 billion in Q2 2025 from $5.2 billion in Q2 2024, representing a 13.5% decline year-over-year.

What was the impact of investment income on Aflac's Q2 2025 results?

Net investment income for Aflac decreased to $600 million in Q2 2025 from $700 million in Q2 2024, contributing to the overall revenue decline and the net loss.

What is Aflac's current asset base as of June 30, 2025?

As of June 30, 2025, Aflac's total assets stood at $125.3 billion, a slight decrease from $126.5 billion reported at December 31, 2024.

How many shares of common stock did Aflac have outstanding at the end of Q2 2025?

Aflac had 580 million shares of common stock outstanding as of June 30, 2025, down from 590 million shares at December 31, 2024.

What does the shift in Aflac's accumulated other comprehensive income (loss) indicate?

The shift from a $1.1 billion gain at December 31, 2024, to a $1.2 billion loss at June 30, 2025, in accumulated other comprehensive income (loss) indicates adverse changes in the fair value of Aflac's investment portfolio.

What are the primary risks highlighted by Aflac's Q2 2025 filing?

The primary risks highlighted are significant exposure to investment market volatility, evidenced by the $2.3 billion net realized investment loss, and a decline in overall revenues, which could impact future profitability and financial stability.

How might Aflac's Q2 2025 performance affect its competitive position?

Aflac's substantial net loss and revenue decline could weaken its competitive position against insurers with more stable investment portfolios or diversified income streams, potentially impacting market share and investor confidence.

What is the outlook for Aflac's profitability given the Q2 2025 results?

The outlook for Aflac's profitability appears challenged in the short term, given the significant net loss of $1.1 billion and the ongoing volatility in the investment environment that led to a $2.3 billion realized investment loss.

Did Aflac engage in any share repurchase activities in Q2 2025?

Yes, Aflac engaged in share repurchase activities, as evidenced by the decrease in common stock outstanding from 590 million shares at December 31, 2024, to 580 million shares at June 30, 2025.

Risk Factors

Industry Context

Aflac operates in the accident and health insurance sector, facing a competitive landscape characterized by established players and evolving consumer needs. The industry is sensitive to economic cycles, interest rate environments, and regulatory changes, particularly in its key markets of Japan and the U.S.

Regulatory Implications

Aflac is subject to extensive regulation in both the U.S. and Japan. Changes in insurance laws, capital requirements, or consumer protection regulations could impact its operations and profitability. Compliance with these diverse regulatory frameworks is a continuous challenge.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Net Realized Investment Loss
Losses incurred when investments are sold for less than their carrying value. This is a key driver of the current quarter's net loss. (The primary reason for Aflac's net loss in Q2 2025, amounting to $2.3 billion.)
Net Investment Income
Income generated from a company's investments, such as interest and dividends, after expenses. It excludes gains or losses from selling investments. (Decreased to $600 million in Q2 2025 from $700 million in Q2 2024, contributing to the overall revenue decline.)
Accumulated Other Comprehensive Income (Loss)
A component of shareholders' equity that includes unrealized gains and losses on investments, foreign currency translation adjustments, and pension adjustments that have not yet been realized. (Shifted from a $1.1 billion gain to a $1.2 billion loss, indicating significant negative valuation changes in the investment portfolio.)
Common Stock Outstanding
The total number of shares of common stock that have been issued by a company and are held by investors. (Decreased to 580 million shares from 590 million, suggesting active share repurchase programs.)

Year-Over-Year Comparison

Compared to the prior-year quarter, Aflac Inc. has experienced a dramatic shift from a net income of $1.2 billion to a net loss of $1.1 billion. Total revenues have fallen by 13.5% to $4.5 billion, and net investment income has decreased. The most significant change is the $2.3 billion net realized investment loss, which is the primary driver of the current quarter's poor performance, and a substantial negative swing in Accumulated Other Comprehensive Income (Loss).

From the Filing

0000004977-25-000132.txt : 20250805 0000004977-25-000132.hdr.sgml : 20250805 20250805160258 ACCESSION NUMBER: 0000004977-25-000132 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 119 CONFORMED PERIOD OF REPORT: 20250630 FILED AS OF DATE: 20250805 DATE AS OF CHANGE: 20250805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AFLAC INC CENTRAL INDEX KEY: 0000004977 STANDARD INDUSTRIAL CLASSIFICATION: ACCIDENT & HEALTH INSURANCE [6321] ORGANIZATION NAME: 02 Finance EIN: 581167100 STATE OF INCORPORATION: GA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-07434 FILM NUMBER: 251184780 BUSINESS ADDRESS: STREET 1: 1932 WYNNTON RD CITY: COLUMBUS STATE: GA ZIP: 31999 BUSINESS PHONE: 7063233431 MAIL ADDRESS: STREET 1: 1932 WYNNTON ROAD CITY: COLUMBUS STATE: GA ZIP: 31999 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FAMILY CORP DATE OF NAME CHANGE: 19920306 10-Q 1 afl-20250630.htm 10-Q afl-20250630 http://www.aflac.com/20250630#JapanNationalGovernmentMember http://www.aflac.com/20250630#JapanNationalGovernmentMember http://www.aflac.com/20250630#JapanNationalGovernmentMember http://www.aflac.com/20250630#JapanNationalGovernmentMember http://www.aflac.com/20250630#JapanNationalGovernmentMember http://www.aflac.com/20250630#JapanNationalGovernmentMember http://fasb.org/us-gaap/2025#OtherAssets http://fasb.org/us-gaap/2025#OtherLiabilities http://fasb.org/us-gaap/2025#OtherAssets http://fasb.org/us-gaap/2025#OtherLiabilities http://fasb.org/us-gaap/2025#NetInvestmentIncome http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#NetInvestmentIncome http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#NetInvestmentIncome http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#NetInvestmentIncome http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#GainLossOnInvestments http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax http://fasb.org/us-gaap/2025#OtherComprehensiveIncomeLossBeforeTax 0000004977 12/31 2025 Q2 FALSE xbrli:shares iso4217:USD iso4217:USD xbrli:shares afl:segment xbrli:pure afl:investment iso4217:JPY afl:series 0000004977 2025-01-01 2025-06-30 0000004977 exch:XNYS 2025-01-01 2025-06-30 0000004977 2025-07-28 0000004977 2025-04-01 2025-06-30 0000004977 2024-04-01 2024-06-30 0000004977 2024-01-01 2024-06-30 0000004977 srt:ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember 2025-06-30 0000004977 srt:ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember 2024-12-31 0000004977 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2025-06-30 0000004977 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2024-12-31 0000004977 2025-06-30 0000004977 2024-12-31 0000004977 us-gaap:CommonStockMember 2024-12-31 0000004977 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0000004977 us-gaap:RetainedEarningsMember 2024-12-31 0000004977 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0000004977 us-gaap:TreasuryStockCommonMember 2024-12-31 0000004977 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0000004977 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0000004977 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0000004977 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0000004977 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0000004977 2025-01-01 2025-03-31 0

View on Read The Filing